Cyclopentolate/ketorolac/phenylephrine/proparacaine/tropicamide ophthalmic Interactions
There are 217 drugs known to interact with cyclopentolate/ketorolac/phenylephrine/proparacaine/tropicamide ophthalmic, along with 7 disease interactions. Of the total drug interactions, 7 are major, and 210 are moderate.
- View disease interactions (7)
Medications known to interact with cyclopentolate/ketorolac/phenylephrine/proparacaine/tropicamide ophthalmic
Note: Showing generic names only.
A
- abciximab
- acalabrutinib
- acebutolol
- acetylcholine ophthalmic
- ado-trastuzumab emtansine
- albuterol
- alteplase
- aminosalicylic acid
- amyl nitrite
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- arformoterol
- argatroban
- aspirin
- atenolol
- atropine
- avapritinib
B
- belladonna
- benztropine
- betaxolol
- betaxolol ophthalmic
- bethanechol
- betrixaban
- biperiden
- bisoprolol
- bitolterol
- bivalirudin
- bupivacaine
- bupivacaine liposome
- bupropion
C
- cabozantinib
- cangrelor
- caplacizumab
- carbachol ophthalmic
- carteolol
- carteolol ophthalmic
- carvedilol
- cevimeline
- chloroprocaine
- chloroquine
- cilostazol
- clidinium
- clopidogrel
- cyclophosphamide
D
- dabigatran
- dalteparin
- danaparoid
- dapsone
- dapsone topical
- dasatinib
- defibrotide
- demecarium bromide ophthalmic
- deserpidine
- desirudin
- desvenlafaxine
- dexamethasone ophthalmic
- dicumarol
- dicyclomine
- dihydroergotamine
- dipyridamole
- donepezil
- drotrecogin alfa
- droxidopa
- duloxetine
E
- echothiophate iodide ophthalmic
- edoxaban
- enoxaparin
- epoprostenol
- eptifibatide
- ergonovine
- ergotamine
- esmolol
- etidocaine
F
- flavoxate
- fluocinolone ophthalmic
- fluorometholone ophthalmic
- flutamide
- fondaparinux
- formoterol
- furazolidone
G
H
I
- ibritumomab
- ibrutinib
- ifosfamide
- iloprost
- indacaterol
- inotersen
- iobenguane I 131
- iodine i 131 tositumomab
- isocarboxazid
- isoetharine
- isoflurophate ophthalmic
- isoproterenol
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
K
L
- labetalol
- lepirudin
- levalbuterol
- levobetaxolol ophthalmic
- levobunolol ophthalmic
- levobupivacaine
- levomilnacipran
- lidocaine
- linezolid
- loteprednol ophthalmic
M
- medrysone ophthalmic
- mepenzolate
- mepivacaine
- metaproterenol
- methscopolamine
- methylene blue
- methylergonovine
- methysergide maleate
- metipranolol ophthalmic
- metoclopramide
- metoprolol
- midodrine
- milnacipran
N
O
P
- panobinostat
- penbutolol
- phenazopyridine
- phenelzine
- phenobarbital
- phenylephrine
- phenytoin
- physostigmine
- physostigmine ophthalmic
- pilocarpine
- pilocarpine ophthalmic
- pindolol
- pirbuterol
- plicamycin
- ponatinib
- prasugrel
- prednisolone ophthalmic
- primaquine
- procaine
- procaine penicillin
- procarbazine
- procyclidine
- propantheline
- propranolol
Q
R
- racepinephrine
- ramucirumab
- rasagiline
- rasburicase
- rauwolfia serpentina
- regorafenib
- reserpine
- reteplase
- rimexolone ophthalmic
- ritodrine
- rivaroxaban
- rivastigmine
- ropivacaine
- ruxolitinib
S
- safinamide
- salmeterol
- scopolamine
- selegiline
- sibutramine
- silver nitrate topical
- silver sulfadiazine topical
- solriamfetol
- sotalol
- streptokinase
- sulfamethizole
- sulfasalazine
- sulfinpyrazone
- sulfisoxazole
T
- tacrine
- tafenoquine
- tapentadol
- tazemetostat
- tenecteplase
- terbutaline
- tetracaine
- ticagrelor
- ticlopidine
- timolol
- timolol ophthalmic
- tinzaparin
- tirofiban
- tositumomab
- tranylcypromine
- treprostinil
- trihexyphenidyl
U
V
W
Z
Cyclopentolate/ketorolac/phenylephrine/proparacaine/tropicamide ophthalmic disease interactions
There are 7 disease interactions with cyclopentolate / ketorolac / phenylephrine / proparacaine / tropicamide ophthalmic which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
